Header Logo

Connection

Mignonette Du Plessis to Pneumococcal Infections

This is a "connection" page, showing publications Mignonette Du Plessis has written about Pneumococcal Infections.
  1. Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013. J Clin Microbiol. 2016 05; 54(5):1326-34.
    View in: PubMed
    Score: 0,421
  2. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa. Int J Antimicrob Agents. 2008 Nov; 32 Suppl 1:S66-70.
    View in: PubMed
    Score: 0,249
  3. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
    View in: PubMed
    Score: 0,189
  4. Meningitis-associated pneumococcal serotype 8, ST 53, strain is hypervirulent in a rat model and has non-haemolytic pneumolysin which can be attenuated by liposomes. Front Cell Infect Microbiol. 2022; 12:1106063.
    View in: PubMed
    Score: 0,169
  5. A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV. Microb Genom. 2022 04; 8(4).
    View in: PubMed
    Score: 0,160
  6. A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa. J Antimicrob Chemother. 2020 03 01; 75(3):512-520.
    View in: PubMed
    Score: 0,139
  7. Genomic differences among carriage and invasive nontypeable pneumococci circulating in South Africa. Microb Genom. 2019 10; 5(10).
    View in: PubMed
    Score: 0,135
  8. Putative novel cps loci in a large global collection of pneumococci. Microb Genom. 2019 07; 5(7).
    View in: PubMed
    Score: 0,132
  9. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis. 2019 07; 19(7):759-769.
    View in: PubMed
    Score: 0,132
  10. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine. 2019 May; 43:338-346.
    View in: PubMed
    Score: 0,130
  11. Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci. PLoS Pathog. 2018 11; 14(11):e1007438.
    View in: PubMed
    Score: 0,127
  12. Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0,123
  13. Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae. J Clin Microbiol. 2018 01; 56(1).
    View in: PubMed
    Score: 0,119
  14. The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1. Vaccine. 2017 02 07; 35(6):972-980.
    View in: PubMed
    Score: 0,111
  15. Understanding pneumococcal serotype 1 biology through population genomic analysis. BMC Infect Dis. 2016 11 08; 16(1):649.
    View in: PubMed
    Score: 0,110
  16. Two cases of serotypeable and non-serotypeable variants of Streptococcus pneumoniae detected simultaneously during invasive disease. BMC Microbiol. 2016 06 24; 16(1):126.
    View in: PubMed
    Score: 0,107
  17. Genomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003-2013. BMC Genomics. 2016 06 22; 17:470.
    View in: PubMed
    Score: 0,107
  18. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One. 2014; 9(9):e107666.
    View in: PubMed
    Score: 0,095
  19. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol. 2014 Sep; 52(9):3271-6.
    View in: PubMed
    Score: 0,093
  20. An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol. 2010 Jan; 48(1):184-91.
    View in: PubMed
    Score: 0,068
  21. Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa. J Clin Microbiol. 2009 May; 47(5):1319-24.
    View in: PubMed
    Score: 0,065
  22. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2009 Feb; 53(2):552-6.
    View in: PubMed
    Score: 0,063
  23. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet. 2008 Mar 29; 371(9618):1108-13.
    View in: PubMed
    Score: 0,061
  24. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Int J Antimicrob Agents. 2008 Jul; 32(1):62-7.
    View in: PubMed
    Score: 0,060
  25. Geographical migration and fitness dynamics of Streptococcus pneumoniae. Nature. 2024 Jul; 631(8020):386-392.
    View in: PubMed
    Score: 0,047
  26. Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother. 2002 Aug; 46(8):2349-57.
    View in: PubMed
    Score: 0,041
  27. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol. 2013 Feb; 51(2):647-52.
    View in: PubMed
    Score: 0,021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.